Improving Care Transitions in Clostridioides Difficile Infection
Released: December 6, 2019, Expires: December 6, 2020
Physicians, Nurse Practitioners, Physician Assistants, Nurses, Pharmacists, and Case Managers
With advances in Clostridioides difficile infection (CDI) treatment and recurrence prevention, and recently updated IDSA/SHEA guidelines, remarkable potential exists to improve CDI patient outcomes through effective interventions at critical transition points.
CDI experts Sahil Khanna, MBBS, and Kevin Garey, PharmD, MS, FASHP, lead this webcast, highlighting core concepts and strategies from the CDI Transitions of Care (TOC) Pathway. The CDI TOC Pathway was developed in partnership with the National Transitions of Care Coalition (NTOCC) to arm system leaders and CDI care teams with essential interventions and tools to ensure safe and effective TOCs for patients with CDI across care settings.
- Overview of the Clostridioides difficile infection (CDI) Transitions of Care Pathway
- How Do Ineffective Care Transitions Impact Patients with CDI?
III. Assessing CDI Risk and Implementing Diagnostic Stewardship
- Advances in the Treatment of Primary and Recurrent CDI
- Engaging CDI Patients and Caregivers in Effective and Safe Care Transitions
Sahil Khanna, MBBS
Kevin W Garey, PharmD, MS, FASHP
Michael R Stinchon, Jr, RPH
Offering 1.0 hour of ACCME, AAPA, AANP, ACPE, ANCC, and CCM credit.
Supporter statement: This activity is provided by PRIME Education. There is no fee to participate. This activity is supported by an educational grant from Merck & Co. Inc.